This study was supported in part by the Centers for Disease Control and Prevention, and the Chevez FAS Fund at Children's Hospital and Medical Center (Seattle, WA).
A Fetal Alcohol Syndrome Screening Tool
Article first published online: 11 APR 2006
Alcoholism: Clinical and Experimental Research
Volume 19, Issue 6, pages 1565–1571, December 1995
How to Cite
Astley, S. J. and Clarren, S. K. (1995), A Fetal Alcohol Syndrome Screening Tool. Alcoholism: Clinical and Experimental Research, 19: 1565–1571. doi: 10.1111/j.1530-0277.1995.tb01025.x
- Issue published online: 11 APR 2006
- Article first published online: 11 APR 2006
- Received for publication March 14, 1995; accepted July 13, 1995
- Fetal Alcohol Syndrome;
The purpose of this study was to derive a multivariate, quantitative case definition of the fetal alcohol syndrome (FAS) facial phenotype from a dysmorphologist-derived gold standard and use it to develop an effective screening tool for identification of children at risk for FAS. The facial and physical features of a racially mixed group of children (0.2–10.0 years of age), evaluated by a single dysmorphologist in the University of Washington FAS Clinic, were used to determine which feature or set of features best differentiated between children with and without a diagnosis of FAS. The study population was divided into two groups balanced on gender, age at examination, race, diagnosis, and date of examination. Group 1 was used to identify the most differentiating feature(s), and group 2 was used to validate the differentiating capability of the feature(s). Group 1 included 97 children (20 with FAS and 77 without FAS). Group 2 included 97 children (19 with FAS and 78 without FAS). Discriminant analysis identified smooth philtrum, thin upper lip, and short palpebral fissures as the cluster of features that best differentiated children with and without FAS based on the discriminant function [D = 1.7953086 + 0.8116083 (thin upper lip) + 2.6411562 (smooth philtrum) - 3.4073780 (% predicted right palpebral fissure length)]. Patients with a D-score ± 1.5 were classified as at-risk for FAS (screen positive). Using this cut-off value for the D-score, children in group 1 were classified with 100% sensitivity (20 of 20 true positives) and 90.0% specificity (70 of 77 true negatives). The children in group 2 were classified with 100% sensitivity (19 of 19 true positives) and 87.3% specificity (68 of 78 true negatives). Across all 194 patients, sensitivity was 100% [95% confidence interval (97–100)] and specificity was 89% [95% confidence interval (85 to 93)]. Seventy-one percent (n= 12) of the 17 false-positives had a true classification of possible fetal alcohol effects. Sensitivity and specificity were unaffected by race, gender, and age through 10 years. This screening tool is effective at differentiating children with and without FAS as diagnosed by a single dysmorphologist (S.K.C.) at the University of Washington FAS Clinic. Assessment of diagnostic interrater agreement between trained dysmorphologists and testing in other clinic populations will be needed to assess the tool's external validity.